|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | C07K 16/28 |
| (11) | Number of the document | 2920209 |
| (13) | Kind of document | T |
| (96) | European patent application number | 13789492.9 |
| Date of filing the European patent application | 2013-11-12 | |
| (97) | Date of publication of the European application | 2015-09-23 |
| (45) | Date of publication and mention of the grant of the patent | 2020-08-05 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/EP2013/003399 |
| Date | 2013-11-12 |
| (87) | Number | WO 2014/075788 |
| Date | 2014-05-22 |
| (30) | Number | Date | Country code |
| PCT/EP2012/0047 | 2012-11-13 | WO | |
| PCT/EP2013/0022 | 2013-07-30 | WO |
| (72) |
SAHIN, Ugur, DE
TÜRECI, Özlem, DE
STADLER, Christiane, DE
HOLLAND, Julia, DE
BÄHR-MAHMUD, Hayat, DE
BEISSERT, Tim, DE
PLUM, Laura, DE
LE GALL, Fabrice, DE
JENDRETZKI, Arne, DE
FIEDLER, Markus, DE
|
| (73) |
TRON - Translationale Onkologie an der Universitätsmedizin der Johannes Gutenberg- Universität Mainz gemeinnützige Gmb,
Freiligrathstrasse 12, 55131 Mainz,
DE
Astellas Pharma Inc., 5-1, Nihonbashi-Honcho 2-Chome, Chuo-ku Tokyo 103-8411, JP BioNTech SE, An der Goldgrube 12, 55131 Mainz, DE |
| (54) | AGENTS FOR TREATMENT OF CLAUDIN EXPRESSING CANCER DISEASES |
| AGENTS FOR TREATMENT OF CLAUDIN EXPRESSING CANCER DISEASES |